对参与孕期疫苗临床试验的母亲所生新生儿的安全性评估。
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.
作者信息
Munoz Flor M, Weisman Leonard E, Read Jennifer S, Siberry George, Kotloff Karen, Friedman Jennifer, Higgins Rosemary D, Hill Heather, Seifert Harry, Nesin Mirjana
机构信息
Department of Pediatrics Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Department of Pediatrics.
出版信息
Clin Infect Dis. 2014 Dec 15;59 Suppl 7(Suppl 7):S415-27. doi: 10.1093/cid/ciu727.
Abstract
A panel of experts convened by the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, developed proposed guidelines for the evaluation of adverse events in newborns of women participating in clinical trials of maternal immunization in the United States.
摘要
美国国立卫生研究院国家过敏和传染病研究所微生物学与传染病司召集了一个专家小组，制定了关于评估参与美国孕产妇免疫临床试验的妇女所生新生儿不良事件的拟议指南。
相似文献
1
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.对参与孕期疫苗临床试验的母亲所生新生儿的安全性评估。
Clin Infect Dis. 2014 Dec 15;59 Suppl 7(Suppl 7):S415-27. doi: 10.1093/cid/ciu727.
2
Research on vaccines during pregnancy: protocol design and assessment of safety.妊娠期疫苗研究：方案设计与安全性评估。
Vaccine. 2013 Sep 13;31(40):4274-9. doi: 10.1016/j.vaccine.2013.07.042. Epub 2013 Jul 29.
3
Maternal immunization: opportunities for scientific advancement.孕产妇免疫接种：科学进步的机遇
Clin Infect Dis. 2014 Dec 15;59 Suppl 7(Suppl 7):S408-14. doi: 10.1093/cid/ciu708.
4
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.妊娠期疫苗研究：生命体征和实验室评估参考值。
Vaccine. 2013 Sep 13;31(40):4264-73. doi: 10.1016/j.vaccine.2013.07.031. Epub 2013 Jul 29.
5
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.孕妇疫苗临床试验中安全性数据的收集、分析与呈现指南。
Vaccine. 2016 Dec 1;34(49):5998-6006. doi: 10.1016/j.vaccine.2016.07.032. Epub 2016 Jul 29.
6
Maternal immunization efforts of the National Institutes of Health.美国国立卫生研究院的孕产妇免疫工作。
Vaccine. 2015 Nov 25;33(47):6380-7. doi: 10.1016/j.vaccine.2015.08.097. Epub 2015 Oct 13.
7
Maternal immunization at the crossroads.处于十字路口的孕产妇免疫接种。
Vaccine. 2015 Nov 25;33(47):6501-2. doi: 10.1016/j.vaccine.2015.06.118. Epub 2015 Aug 6.
8
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country.从南非（一个中低收入国家）孕妇及其婴儿参与临床试验的招募和随访中吸取的经验教训。
Vaccine. 2015 Nov 25;33(47):6406-12. doi: 10.1016/j.vaccine.2015.08.040. Epub 2015 Sep 26.
9
Maternal immunization: an update for pediatricians.孕产妇免疫接种：给儿科医生的最新资讯
Pediatr Ann. 2013 Aug;42(8):153-8. doi: 10.3928/00904481-20130723-09.
10
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.孕期疫苗临床试验中用于评估安全性的病例报告表变量收集指南。
Vaccine. 2016 Dec 1;34(49):6007-6014. doi: 10.1016/j.vaccine.2016.07.007. Epub 2016 Oct 25.
引用本文的文献
1
Infection Leading to Breast Abscess Formation in Pregnancy: A Case Report.妊娠期感染导致乳腺脓肿形成：一例报告
Int Med Case Rep J. 2025 Jul 4;18:791-809. doi: 10.2147/IMCRJ.S512859. eCollection 2025.
2
Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial.在感染 HIV 的孕妇中接种结合疫苗和多糖疫苗的安全性、免疫原性和胎盘抗体转运：一项多中心随机对照试验。
Lancet HIV. 2021 Jul;8(7):e408-e419. doi: 10.1016/S2352-3018(20)30339-8. Epub 2021 Apr 27.
3
Coronavirus disease 2019 vaccines in pregnancy.2019冠状病毒病疫苗在孕期的应用
Am J Obstet Gynecol MFM. 2021 Mar;3(2):100295. doi: 10.1016/j.ajogmf.2020.100295. Epub 2020 Dec 10.
4
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.孕妇疫苗临床试验中安全性数据的收集、分析与呈现指南。
Vaccine. 2016 Dec 1;34(49):5998-6006. doi: 10.1016/j.vaccine.2016.07.032. Epub 2016 Jul 29.
5
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.新生儿死亡：免疫接种安全性数据的病例定义及数据收集、分析与呈现指南。
Vaccine. 2016 Dec 1;34(49):6027-6037. doi: 10.1016/j.vaccine.2016.03.040. Epub 2016 Jul 19.
6
A systematic review of adverse events following immunization during pregnancy and the newborn period.孕期及新生儿期免疫接种后不良事件的系统评价。
Vaccine. 2015 Nov 25;33(47):6453-65. doi: 10.1016/j.vaccine.2015.08.043. Epub 2015 Sep 26.
7
Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.评估孕期疫苗安全性的关键术语：启动不良事件定义协调统一的全球协商进程结果
Vaccine. 2015 Nov 25;33(47):6441-52. doi: 10.1016/j.vaccine.2015.07.112. Epub 2015 Sep 19.
8
Moving targets: The challenges of studying infectious diseases among pregnant women in resource limited settings.移动目标：在资源有限环境中研究孕妇传染病的挑战。
Vaccine. 2015 Nov 25;33(47):6401-5. doi: 10.1016/j.vaccine.2015.08.042. Epub 2015 Aug 25.
本文引用的文献
1
Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.对参与临床试验的孕妇所生婴儿先天性异常的评估。
Clin Infect Dis. 2014 Dec 15;59 Suppl 7(Suppl 7):S428-36. doi: 10.1093/cid/ciu738.
2
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.孕妇接种破伤风白喉无细胞百日咳（Tdap）疫苗的安全性和免疫原性：一项随机临床试验。
JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633.
3
Research on vaccines during pregnancy: protocol design and assessment of safety.妊娠期疫苗研究：方案设计与安全性评估。
Vaccine. 2013 Sep 13;31(40):4274-9. doi: 10.1016/j.vaccine.2013.07.042. Epub 2013 Jul 29.
4
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.妊娠期疫苗研究：生命体征和实验室评估参考值。
Vaccine. 2013 Sep 13;31(40):4264-73. doi: 10.1016/j.vaccine.2013.07.031. Epub 2013 Jul 29.
5
Preventing newborn infection with maternal immunization.通过母体免疫预防新生儿感染。
Sci Transl Med. 2013 Jul 24;5(195):195ps11. doi: 10.1126/scitranslmed.3005451.
6
ACOG Committee Opinion No. 566: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination.美国妇产科医师学会委员会意见 No.566：免疫接种和妊娠更新：破伤风、白喉和百日咳疫苗接种。
Obstet Gynecol. 2013 Jun;121(6):1411-1414. doi: 10.1097/01.AOG.0000431054.33593.e3.
7
Immune responses in infants whose mothers received Tdap vaccine during pregnancy.孕妇在孕期接种 Tdap 疫苗对婴儿的免疫应答。
Pediatr Infect Dis J. 2013 Nov;32(11):1257-60. doi: 10.1097/INF.0b013e3182a09b6a.
8
Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants.母体免疫接种作为降低新生儿感染易感性的策略。
Curr Opin Infect Dis. 2013 Jun;26(3):248-53. doi: 10.1097/QCO.0b013e3283607a58.
9
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.更新的孕妇破伤风类毒素、白喉类毒素和无细胞百日咳疫苗（Tdap）使用建议——免疫实践咨询委员会（ACIP），2012 年。
MMWR Morb Mortal Wkly Rep. 2013 Feb 22;62(7):131-5.
10
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.脑膜炎球菌病研究重点及 A 群脑膜炎球菌疫苗接种对非洲脑膜炎地带的影响。
Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.
Zotero 插件